EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment

Gisli G Einarsson, Laura J Sherrard, Joseph E Hatch, Bryan Zorn, Elinor Johnston, Clodagh McGettigan, Katherine O'Neill, Deirdre F Gilpin, Damian G Downey, Michelle Murray, Gillian Lavelle, Gerry McElvaney und 6 weitere

Journal of Cystic Fibrosis · 2024-03 · 23 (2) · 252-261

DOI: 10.1016/j.jcf.2023.11.010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Cystic Fibrosis, 2024-03. Verfasst von Gisli G Einarsson und 17 weiteren Autor:innen. Beteiligte Einrichtung: Queen's University Belfast, Belfast, United Kingdom. Electronic address: g.einarsson@qub.ac.uk. Hauptthemen laut MEDLINE: Cystic Fibrosis, Anti-Bacterial Agents, Microbiota, Sputum. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Public Health Agency, Health and Social Care Research and Development Division.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Whether there is any benefit in integrating culture-independent molecular analysis of the lower airway microbiota of people with cystic fibrosis into clinical care is unclear. This study determined the longitudinal trajectory of the microbiota and if there were microbiota characteristics that corresponded with response to treatment or predicted a future pulmonary exacerbation. METHODS: At least one sputum sample was collected from 149 participants enrolled in this prospective longitudinal multi-centre study and total bacterial density and microbiota community measurements were determined and compared with clinical parameters. RESULTS: In 114 participants with paired samples when clinically stable, ∼8 months apart, the microbiota remained conserved between timepoints, regardless of whether participants received acute intravenous antibiotic treatment or not. In 62 participants, who presented with an acute exacerbation, a decrease in community richness correlated best with patient response to antibiotic treatment. Analysis of baseline samples from 30 participants who exacerbated within 4 months of their stable sample being collected and 72 participants who remained stable throughout the study showed that community characteristics such as lower richness at baseline may be predictive of an exacerbation in addition to several clinical parameters. However, lasso regression analysis indicated that only lung function (p = 0.014) was associated with a future exacerbation. CONCLUSIONS: The airway microbiota remains stable over periods

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisAnti-Bacterial AgentsMicrobiotaSputumHumansMaleFemaleLongitudinal StudiesProspective StudiesAdultDisease ProgressionAdolescentRespiratory Function Tests

Stichwörter der Autor:innen

ExacerbationsMicrobiotaPseudomonas aeruginosaRespiratory infections

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Queen's University Belfast, Belfast, United Kingdom. Electronic address: g.einarsson@qub.ac.uk.
  • Queen's University Belfast, Belfast, United Kingdom.
  • University of North Carolina, Chapel Hill, NC, United States.
  • Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland.
  • Frontier Science (Scotland) Ltd., Kincraig, United Kingdom.

Förderung

  • NHLBI NIH HHS
  • Public Health Agency
  • Health and Social Care Research and Development Division
  • Health and Social Care Northern Ireland
  • Department for Employment and Learning, Northern Ireland
  • National Institute for Health and Care Research
  • National Institutes of Health

Zitieren

APA

Einarsson, G. G., Sherrard, L. J., Hatch, J. E., Zorn, B., Johnston, E., McGettigan, C., O'Neill, K., Gilpin, D. F., Downey, D. G., Murray, M., Lavelle, G., McElvaney, G., Wolfgang, M. C., Boucher, R., Muhlebach, M. S., Bradbury, I., Elborn, J. S., & Tunney, M. M. (2024). Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment. Journal of Cystic Fibrosis, 23(2), 252-261. https://doi.org/10.1016/j.jcf.2023.11.010

Vancouver

Einarsson GG, Sherrard LJ, Hatch JE, Zorn B, Johnston E, McGettigan C, et al. Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment. Journal of Cystic Fibrosis. 2024;23(2):252-261. doi:10.1016/j.jcf.2023.11.010

BibTeX
@article{Einarsson2024,
  author = {Einarsson, Gisli G and Sherrard, Laura J and Hatch, Joseph E and Zorn, Bryan and Johnston, Elinor and McGettigan, Clodagh and O'Neill, Katherine and Gilpin, Deirdre F and Downey, Damian G and Murray, Michelle and Lavelle, Gillian and McElvaney, Gerry and Wolfgang, Matthew C and Boucher, Richard and Muhlebach, Marianne S and Bradbury, Ian and Elborn, J Stuart and Tunney, Michael M},
  title = {Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment},
  journal = {Journal of Cystic Fibrosis},
  year = {2024},
  volume = {23},
  number = {2},
  pages = {252--261},
  doi = {10.1016/j.jcf.2023.11.010}
}
Kostenlos starten →